Concepedia

Igor Moskalev

IM

19

Publications

658

Citations

14

H-Index

2013

Active since

Affiliations

University of British Columbia(Current)

Johannes Gutenberg University Mainz

Vancouver General Hospital

The Prostate Centre

University of Copenhagen

Igor Moskalev is an author at University of British Columbia specializing in medicine, urology, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2023

19

Publications

19

Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo et al. · The Journal of Urology · 2015 · 84 citations

Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer

Luuk van Hooren, Linda C. Sandin, Igor Moskalev et al. · European Journal of Immunology · 2016 · 74 citations · Full text

, , +17

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer

Tilman Todenhöfer, Roland Seiler, Craig Stewart et al. · Molecular Cancer Therapeutics · 2018 · 69 citations

Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach

Wolfgang Jäger, Igor Moskalev, Tetsutaro Hayashi et al. · PLoS ONE · 2013 · 53 citations · Full text

Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells

Kevin J. Tam, Daniel H. Hui, Wilson W. Lee et al. · Scientific Reports · 2017 · 53 citations · Full text

Rows per page

1–5 of 19